Hepatitis Forums
Advanced Liver Disease Main Forums => Advanced Liver Disease => Topic started by: Hep Editors on January 04, 2017, 02:19:16 pm
-
Gilead Sciences’ Harvoni (ledipasvir/sofosbuvir) is safe and effective for people with kidney transplants undergoing treatment for hepatitis C virus (HCV), Healio reports.
Publishing their findings in the Annals of Internal Medicine, researchers conducted a Phase II, open-label study of 114 people with genotype 1 or 4 of hep C who had received a transplanted kidney at least six months before entering the study. The participants, 69 percent of whom were being treated for HCV for the first time, were evenly randomized to receive 12 or 24 weeks of Harvoni.
Read more...
https://www.hepmag.com/article/kidney-transplantees-harvoni-hepatitis-c